NIMCO US, Inc., 10% Owner at Aimmune Therapeutics, Inc. (AIMT), bought 7,412,558 shares at $32.00 ($226.0M) on 2018-02-26, disclosed to the SEC on 2020-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.00 | 937,500 | $30.0M | 13.3% |
| 2 | $30.27 | 3,237,529 | $98.0M | 43.4% |
| 3 | $30.27 | 3,237,529 | $98.0M | 43.4% |
| Total | $30.49 avg | 7,412,558 | $226.0M | 100% |